| Document Date: 2015-04-09 06:01:23
Open Document File Size: 359,53 KBShare Result on Facebook
City Shanghai / / Company ZAI Lab Limited / Sanofi / / Continent Asia / / Country United States / China / / / Event Business Partnership / / IndustryTerm treatment of chronic respiratory diseases / manufacturing / media enquiries / pharmaceutical / / MedicalCondition chronic respiratory diseases / COPD / idiopathic pulmonary fibrosis / Pulmonary exacerbations / shortness of breath / chronic obstructive pulmonary disease / Chronic Respiratory Diseases Chronic / viral infections / diseases / chronic diseases / cough / chronic inflammatory disorder / inflammation / respiratory diseases / asthma / / Organization World Health Organization / / Person Samantha Du / Jonathan Wang / / / Position CEO / / Technology drug development / / URL www.zailaboratory.com / /
SocialTag |
ZAI Lab announces a global licensing agreement with Sanofi for two novel compounds in chronic respiratory diseases ShanghaiZAI Lab Limited (ZAI Lab), an innovative biotech company in China, announced today